COMMUNIQUÉS West-GlobeNewswire

HealthLynked Corp. Announces Dr. Michael Dent, CEO is presenting at the NIBA New York Conference on March 27, 2018
21/03/2018
NAPLES, Fla., March 21, 2018 (GLOBE NEWSWIRE) -- HealthLynked Corp. (OTCQB:HLYK) today announced that Dr. Michael Dent, its Chief Executive Officer, is presenting at the National Investment Bankers Association (NIBA). [...]
FIT Biotech Oy: FIT Biotech Oy converts Convertible Capital Notes into shares and exceeds the authorization granted in the Extraordinary General Meeting on February 6, 2018
21/03/2018
FIT Biotech Oy Company release March 21, 2018 at 03:30 PM EET FIT Biotech Oy converts Convertible Capital Notes into shares and exceeds the authorization granted in the Extraordinary General Meeting on February 6, 2018 [...]
ProPhase Labs Reports Financial Results for the Year Ended December 31, 2017
21/03/2018
DOYLESTOWN, Pa., March 21, 2018 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH ), ( www.ProPhaseLabs.com ) today reported its net sales from continuing operations were $9.9 million for the year ended December 31 [...]
Immunicum AB: Invitation to Investor Events
21/03/2018
Press Release 21 March 2018 Immunicum AB: Invitation to Investor Events Immunicum AB (publ; IMMU.ST) a biopharmaceutical company advancing a novel, immune-priming cancer treatment against a variety of solid tumors, [...]
NewLink Genetics Appoints Chad A. Johnson to Board of Directors
21/03/2018
AMES, Iowa, March 21, 2018 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ: NLNK ) today announced the appointment of Chad A. Johnson, 39, to the Company's Board of Directors. In connection with this [...]
AXIM Biotech to Attend BioCentury’s 25th Annual Future Leaders in the Biotech Industry Conference in New York
21/03/2018
NEW YORK, March 21, 2018 (GLOBE NEWSWIRE) -- AXIM ® Biotechnologies, Inc . (AXIM ® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that George E. Anastassov, MD, DDS, MBA and [...]
Devonian Announces Grant of Options
21/03/2018
QUEBEC CITY, March 21, 2018 (GLOBE NEWSWIRE) -- Devonian Health Group Inc. (" Devonian " or the " Corporation ") (TSX VENTURE:GSD) announces that the Board of Directors has approved the grant of options (the ‘‘Options [...]
Devonian annonce l’octroi d’options
21/03/2018
QUÉBEC, 21 mars 2018 (GLOBE NEWSWIRE) -- Groupe Santé Devonian Inc. (« Devonian » ou la « Société ») (TSX CROISSANCE:GSD) annonce que le conseil d'administration a approuvé l'octroi d'options (les «options») pour [...]
Aquinox to Present at the 17th Annual Needham Healthcare Conference
21/03/2018
VANCOUVER, British Columbia, March 21, 2018 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“ Aquinox ”) (NASDAQ: AQXP ), a clinical-stage pharmaceutical company discovering and developing novel drug candidates to [...]
Scapa Healthcare Starts Construction on New Medical Device Manufacturing Facility in Knoxville, TN
21/03/2018
WINDSOR, Conn., March 21, 2018 (GLOBE NEWSWIRE) -- Scapa Healthcare , a trusted strategic outsource partner of skin-friendly, turnkey solutions for advanced wound care, medical device and consumer wellness markets, is [...]
SELLAS Life Sciences Announces Appointment of Barbara A. Wood as Executive Vice President, General Counsel and Corporate Secretary
21/03/2018
NEW YORK, March 21, 2018 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group Inc., (Nasdaq: SLS ) (SELLAS), a clinical-stage biopharmaceutical company focused on novel cancer immunotherapies for a broad range of cancer [...]
Allovate Therapeutics Announces Issuance of Second Japanese Patent, Expanding Global Coverage of the Oral Mucosal Immunotherapy Platform
21/03/2018
New York, March 21, 2018 (GLOBE NEWSWIRE) -- Allovate Therapeutics, a biopharmaceutical company focused on improving treatment options for allergies, announced today that the Japan Patent Office (JPO) has recently [...]
Precision Therapeutics Subsidiary, TumorGenesis, Announces License Agreement with CellBridge Incorporated
21/03/2018
MINNEAPOLIS, March 21, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT ) (“Precision” or “the Company”), formerly Skyline Medical, announced today that its wholly owned subsidiary, TumorGenesis Inc., [...]
Teligent, Inc. Announces FDA Approval of Halobetasol Propionate Ointment, 0.05%
21/03/2018
BUENA, N.J., March 21, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT ), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s abbreviated new drug [...]
Bespoke Extracts’ Sponsored Sportsbike Racer Robertino Pietri Takes Third Place at 77th Annual Running of the Daytona 200
21/03/2018
SUNNY ISLES, Fla., March 21, 2018 (GLOBE NEWSWIRE) -- Bespoke Extracts, Inc. (OTC Pink:BSPK), producer of high quality, great tasting, hemp-derived CBD extract products, is pleased to announce that in the debut of its [...]
Vectura Group plc: 2017 Preliminary Results - Performance in-line with expectations, with strong in-market growth from key inhaled products
21/03/2018
Vectura Group plc 2017 Preliminary Results - Performance in-line with expectations, with strong in-market growth from key inhaled products - Chippenham, UK - 21 March 2018: Vectura Group plc (LSE: VEC) ("Vectura", "the [...]
Enzymatica AB: Notice of annual general meeting in Enzymatica AB (publ)
21/03/2018
The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation, the Swedish text shall prevail. Press release Lund on March 21, 2018 Notice of annual [...]
Sun BioPharma Provides Business Update and Files Annual Report for 2017
21/03/2018
Front-Line Combination Study with Gemcitabine and Nab-Paclitaxel to begin patient enrollment early in 2 nd Quarter Raised $1.3M in private financing MINNEAPOLIS, March 21, 2018 (GLOBE NEWSWIRE) -- Sun BioPharma, Inc. ( [...]
Achaogen Announces Date of FDA Advisory Committee Meeting for Plazomicin
21/03/2018
-- Meeting planned for May 2, 2018 -- SOUTH SAN FRANCISCO, Calif., March 21, 2018 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ: AKAO ), a late-stage biopharmaceutical company developing innovative antibacterials [...]

Pages